Cargando…
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection
Passive administration of neutralizing antibodies (Abs) is an attractive strategy for the control of gastrointestinal infections. However, an unanswered practical concern is the need to assure the stability of sufficient amounts of orally administered neutralizing Abs against intestinal pathogens (e...
Autores principales: | Yuki, Yoshikazu, Zuo, Fanglei, Kurokawa, Shiho, Uchida, Yohei, Sato, Shintaro, Sakon, Naomi, Hammarström, Lennart, Kiyono, Hiroshi, Marcotte, Harold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863548/ https://www.ncbi.nlm.nih.gov/pubmed/36678692 http://dx.doi.org/10.3390/pharmaceutics15010063 |
Ejemplares similares
-
Human Norovirus Propagation in Human Induced Pluripotent Stem Cell–Derived Intestinal Epithelial Cells
por: Sato, Shintaro, et al.
Publicado: (2018) -
Development of Antibody-Fragment–Producing Rice for Neutralization of Human Norovirus
por: Sasou, Ai, et al.
Publicado: (2021) -
Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?
por: Kalusche, Sarah, et al.
Publicado: (2020) -
Replication of Human Sapovirus in Human-Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells
por: Matsumoto, Naomi, et al.
Publicado: (2023) -
Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection
por: Pendharkar, Sonal, et al.
Publicado: (2015)